首页>
外国专利>
COMBINATION THERAPY WITH NK3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SCHIZOPHRENIA
COMBINATION THERAPY WITH NK3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SCHIZOPHRENIA
展开▼
机译:NK3受体拮抗剂联合治疗精神分裂症
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a combination of a NK3 receptor antagonist with a 5HT2A receptor antagonist and/or a D2 receptor antagonist, and the use of the combination in treating schizophrenia and associated conditions.
展开▼